Studies on Incyte drug to be presented at ASCO, EHA conferences
Incyte Corp. announced that approximately 20 abstracts associated with its clinical developments will be presented at the American Society of Clinical Oncology (ASCO) and the European Hematology Association (EHA) meetings in 2016. Read More »